Patients Report Memory Problems After Mild COVID-19
Patients who self-report memory problems eight months after COVID-19 often perceive worsening of health compared with one year prior
Miscellaneous Neurodegenerative Disorders
Dietary Flavonoids May Lower Odds of Subjective Cognitive Decline
Associations strongest for flavones, flavanones, anthocyanins; dose-response curve steepest for flavones, then anthocyanins
Ravulizumab Looks Promising for Generalized Myasthenia Gravis
The randomized, double-blind, placebo-controlled phase 3 study included 175 adults with generalized myasthenia gravis who were not previously treated with a complement inhibitor.
Exservan Now Available for Amyotrophic Lateral Sclerosis
According to the CDC, more than a thousand cases of myocarditis and pericarditis following mRNA COVID-19 vaccination have been reported to the Vaccine Adverse Event Reporting System since April 2021.
FDA to Review Vutrisiran for Polyneuropathy of Hereditary ATTR Amyloidosis
Vutrisiran is an investigational, subcutaneously-administered RNAi therapeutic designed to block the production of wild-type and mutant transthyretin protein.
Certain Antihypertensive Agents May Aid Cognition in Elderly
Memory recall better for up to 3 years with blood-brain barrier-crossing renin-angiotensin drugs versus nonpenetrant counterparts
Three FDA Advisers Quit Over Agency Approval of Aduhelm
Several experts have said the available evidence about Aduhelm raises significant doubts about its effectiveness
Guidelines Developed for Diagnosing, Treating Botulism
Signs and symptoms of some neurologic conditions overlap with botulism; thorough, serial neurologic exams should be conducted.
AAN: Race May Affect Response to Anti-CD20 Therapy for MS, NMOSD
B-cell repopulation occurs more often in African American vs White patients between 6 and 12 months after anti-CD20 infusion
Considerable Neurologic, Psychiatric Morbidity Reported After COVID-19
Estimated incidence of neurological or psychiatric diagnosis was 33.62 percent among 236,379 patients
